We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Prospective, Multi-Centre Trial of TKI Redifferentiation Therapy in Patients With RAIR Thyroid Cancer (I-FIRST Study) (I-FIRST)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT05182931
Recruitment Status : Recruiting
First Posted : January 10, 2022
Last Update Posted : August 1, 2022
Sponsor:
Collaborators:
Royal North Shore Hospital
Austin Health
Sir Charles Gairdner Hospital
Monash Health
Peter MacCallum Cancer Centre, Australia
Royal Brisbane and Women's Hospital
Eastern Health
The Alfred
Information provided by (Responsible Party):
Olivia Newton-John Cancer Research Institute

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : December 30, 2024
Estimated Study Completion Date : December 30, 2025